Knowledge about the drug's structure would help researchers understand what happened.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
CSL-Tox: an open-source analytical framework for the comparison of short-term and long-term toxicity end points and assessing the need of chronic studies in drug development
Scientific Reports Open Access 08 September 2023
-
A CTSA One Health Alliance guidance on institutional review of veterinary clinical studies
BMC Veterinary Research Open Access 17 February 2021
-
When could human challenge trials be deployed to combat emerging infectious diseases? Lessons from the case of a Zika virus human challenge trial
Trials Open Access 19 December 2019
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Additional information
Related links
Related links
Related links in Nature Research
Fresh light thrown on tragic drug trial 2007-Jan-25
New test could weed out dangerous drug trials 2006-Dec-07
Drug to blame for clinical-trial disaster? 2006-Apr-05
Related external links
Rights and permissions
About this article
Cite this article
Butler, D., Callaway, E. Scientists in the dark after French clinical trial proves fatal. Nature 529, 263–264 (2016). https://doi.org/10.1038/nature.2016.19189
Published:
Issue date:
DOI: https://doi.org/10.1038/nature.2016.19189
This article is cited by
-
CSL-Tox: an open-source analytical framework for the comparison of short-term and long-term toxicity end points and assessing the need of chronic studies in drug development
Scientific Reports (2023)
-
A CTSA One Health Alliance guidance on institutional review of veterinary clinical studies
BMC Veterinary Research (2021)
-
When could human challenge trials be deployed to combat emerging infectious diseases? Lessons from the case of a Zika virus human challenge trial
Trials (2019)
-
Why statistical inference from clinical trials is likely to generate false and irreproducible results
BMC Medical Research Methodology (2017)
-
Molecular mechanisms involved in the side effects of fatty acid amide hydrolase inhibitors: a structural phenomics approach to proteome-wide cellular off-target deconvolution and disease association
npj Systems Biology and Applications (2016)
